Lemonade Down 10% on the Week as Shorts Build Into Earnings

LMND fell 10% over the past week to close at $41.34, a move that stands in stark contrast to the median 2.4% gain across its closest peers, and it arrives with the company's Q3 results due Wednesday morning.

Short interest has been climbing quietly but consistently for a month. It now represents nearly 16% of the free float, up from roughly 14% at the start of October, a 9% increase over the past 30 days. The pace of that build is more notable than the absolute level: short sellers added nearly 550,000 shares in the first three days of this week alone. FINRA's most recent fortnightly settlement figure put days-to-cover at 9.65, which means unwinding the position is not a quick trade. Despite all this, the borrow market is not tight. Availability has eased from roughly 335% in late September to around 390% today, meaning there are nearly four shares available to lend for every one already borrowed. Borrowing costs have actually fallen 12% over the past month to below 0.4%, so there is no friction preventing new shorts from entering. The ORTEX short score has risen from 67.2 to 70.1 over the past two weeks, its highest reading in recent data, placing LMND in the 4th percentile for short positioning across the market, a bearish rank.

Options are telling the opposite story. The put/call ratio has dropped sharply to 0.51, more than two standard deviations below its 20-day mean of 0.57. That is close to the 52-week low of 0.39, and it reflects unusually heavy call positioning relative to puts. The divergence between rising short interest and a low put/call ratio is the central tension in LMND's setup right now: equity short sellers are adding to bearish bets while options traders are skewed toward the upside.

The Street has been uniformly cautious, with no upgrades in recent months and a string of target reductions following the Q2 results in late July. Morgan Stanley, the most active voice on the name, downgraded the stock from Overweight to Equal-Weight in July and then cut its target again in early October from $56 to $48, a level now above the current price of $41 but far below where the stock was trading in June. Piper Sandler slashed its target from $75 to $51 in the same post-Q2 wave. The mean target across the analyst group is $58.44, implying about 41% upside from current levels, but that figure is flattered by older targets and should be read cautiously given how rapidly the stock has repriced. Valuation is not simple: the EV/EBITDA multiple sits at 236, though the company is loss-making, and the price-to-book ratio of 6.5 has compressed about 10% over the past 30 days. EPS momentum scores rank in the 1st to 5th percentile over both 30-day and 90-day windows, the weakest part of LMND's factor profile.

The bull case rests on operating leverage that is genuinely materialising. Lemonade's AI-first model has cut the loss adjustment expense ratio from 13% to 6% over three years, with roughly 80% of claims now processed without human involvement. In-force premium topped $1.333 billion in Q1 and the gross loss ratio improved 12 percentage points year-on-year to 61%. Pet insurance surpassed $500 million in IFP and European premium grew 103% quarter-on-quarter across four markets. The target, repeatedly affirmed, is adjusted EBITDA profitability in Q4 2026. The bear case is simply that the path there keeps slipping: home insurance is still shrinking, the autonomous car product is confined to a few states, elevated loss ratios in home and Europe remain a concern, and stock-based compensation has risen sharply. Earnings have punished shareholders twice in a row: the stock fell 21.8% the day after Q2 results and 5.3% after the most recent October print.

BlackRock added over a million shares in the period to September 30 and now holds 7.8% of the company. JPMorgan Chase has also been building, disclosing a 7% stake in a 13G/A filed in late July, up from 5.9% previously. SoftBank, by contrast, has been cutting its position from 8.1% to 4.8%. All 13D/G positions are as last disclosed and holders dropping below the 5% threshold may exit without filing again.

Wednesday's Q3 print is the immediate focus: whether Lemonade narrows its EBITDA loss on schedule, what the gross loss ratio in home and Europe looks like, and whether management maintains the Q4 profitability target.